Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
Adicet Bio, Inc. made a total of 32 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.30
Date | Dividend | Adj Dividend |
---|---|---|
September 21, 18 | $0.00 | $0.01 |
June 07, 18 | $0.00 | $0.01 |
March 08, 18 | $0.01 | $0.07 |
December 15, 17 | $0.01 | $0.07 |
September 07, 17 | $0.01 | $0.07 |
June 07, 17 | $0.01 | $0.07 |
March 08, 17 | $0.01 | $0.07 |
December 08, 16 | $0.01 | $0.07 |
September 07, 16 | $0.01 | $0.07 |
June 07, 16 | $0.01 | $0.06 |
March 09, 16 | $0.01 | $0.06 |
December 15, 15 | $0.01 | $0.06 |
September 17, 15 | $0.01 | $0.06 |
June 09, 15 | $0.01 | $0.06 |
March 10, 15 | $0.01 | $0.06 |
December 11, 14 | $0.01 | $0.06 |
September 11, 14 | $0.01 | $0.06 |
June 10, 14 | $0.01 | $0.06 |
March 11, 14 | $0.01 | $0.06 |
December 12, 13 | $0.01 | $0.06 |
September 12, 13 | $0.01 | $0.06 |
June 12, 13 | $0.01 | $0.06 |
March 13, 13 | $0.01 | $0.06 |
December 13, 12 | $0.01 | $0.06 |
September 13, 12 | $0.01 | $0.06 |
June 07, 12 | $0.01 | $0.10 |
December 23, 11 | $0.01 | $0.10 |
June 09, 11 | $0.01 | $0.10 |
December 22, 10 | $0.01 | $0.10 |
June 10, 10 | $0.01 | $0.10 |
December 22, 09 | $0.01 | $0.10 |
June 11, 09 | $0.01 | $0.10 |